Dr. Purcell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Summary
- Dr. Tom Purcell is the chief medical officer of the Fred Hutchinson Cancer Center. In this role, he oversees Fred Hutch's outpatient clinics and is responsible for ensuring that Fred Hutch provides high-quality clinical care. He also studies the role of exercise in cancer survivorship and carries out clinical trials of new drugs for patients with lung cancer, mesothelioma and other cancers. Dr. Purcell is a medical oncologist who cares for patients at Fred Hutch with gastrointestinal cancers, such as liver cancer.
Education & Training
- Johns Hopkins UniversityFellowship, Medical Oncology, 2002
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1996 - 1999
- Emory University School of MedicineClass of 1996
Certifications & Licensure
- WA State Medical License 2021 - 2026
- CO State Medical License 2012 - 2025
- ID State Medical License 2023 - 2025
- MT State Medical License 2003 - 2025
- ND State Medical License 2003 - 2011
- WY State Medical License 2006 - 2011
- MD State Medical License 2000 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsPatterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database.Arya Amini, Bernard L. Jones, Priscilla K. Stumpf, Stephen Leong, Christopher H. Lieu
Pancreas. 2017-08-01 - 22 citationsDevelopment of matrix metalloproteinase inhibitors in cancer therapyW. Thomas Purcell, Michelle A. Rudek, Manuel Hidalgo
Hematology/oncology Clinics of North America. 2002-10-01 - 113 citationsTherapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab GovitecanRebecca S. Heist, Michael J. Guarino, Gregory A. Masters, W. Thomas Purcell, Alexander Starodub
Journal of Clinical Oncology. 2017-05-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: